---
title: "Weekly Recap | Netlist, Inc. +1.8%, ITC HBM patent complaint"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/300850191.md"
description: "Netlist rose 1.8% this week to $5.66, outperforming the S&P 500 by roughly 2.07 percentage points. The path was uneven: Monday dropped to a low of $5.266, Thursday touched $5.92 before giving back part of the gains, and Friday settled just above the prior close. The stock pushed higher midweek while the broader market slipped, with the final session paring the move."
datetime: "2026-10-03T07:19:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/300850191.md)
  - [en](https://longbridge.com/en/news/300850191.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/300850191.md)
generator: "portal-rs"
---

# Weekly Recap | Netlist, Inc. +1.8%, ITC HBM patent complaint

## The Week

Netlist rose 1.8% this week to $5.66, outperforming the S&P 500 by roughly 2.07 percentage points. The path was uneven: Monday dropped to a low of $5.266, Thursday touched $5.92 before giving back part of the gains, and Friday settled just above the prior close. The stock pushed higher midweek while the broader market slipped, with the final session paring the move.

## Key Events

The week centred on patents and regulation. Monday’s recap flagged the ITC’s 337 probe into DRAM and revenue effects from memory and device pricing. On Tuesday Netlist filed an ITC complaint accusing Micron, Nvidia, Broadcom and Google of infringing its HBM patents. Wednesday’s coverage focused on Netlist seeking a US import ban on memory involving Nvidia, Google and Broadcom products, pulling Micron back into a patent dispute. Separately, headlines noted a 60% jump in payment volumes and shifting small-cap activity. On Thursday Roth MKM initiated Netlist with a buy rating.

## Analyst Ratings

Roth MKM gave Netlist a buy rating this week. Among current coverage, 1 firm rates it buy or overweight, 0 hold, and 0 underweight or sell, out of 1 total. Consensus rating is strong buy, with a consensus target of $15, about 165.0% above the latest price of $5.66. The single target leaves a tight high-low range of $15, so dispersion is limited. Netlist ranks 61st among 67 names in the electronic equipment and services industry.

## The Week Ahead

Next week’s US macro calendar is dense. Monday brings final S&P Global services PMI (prior 58.7) and ISM non-manufacturing PMI (prior 55.4, forecast 55). Tuesday has international trade (prior -88.6, forecast -102) and goods trade balance. Wednesday features EIA weekly crude and Cushing inventory data. The services indicators and trade balance will update the macro picture, while any ITC procedural follow-through on the patent filing is a key stock-specific watch point.

## In Short

The signals point to a divergence. Brokers hold a strong-buy consensus with a target well above spot, but coverage is thin at one firm and the industry rank sits at 61 of 67. The stock rose 1.8% while showing an 11.58% intra-week amplitude and a fade from highs. The ITC complaint and import-ban push add volatility, and valuation readings vary widely: P/B around 92.3x, while P/E on a TTM basis is much lower. What matters next is whether the patent process advances and how services PMI data shapes risk appetite.

*This article is generated by LongbridgeAI from market data, for information only and not investment advice.*

### Related Stocks

- [NLST.US](https://longbridge.com/en/quote/NLST.US.md)

## Related News & Research

- [Why Netlist (NLST) Is Back In The Spotlight](https://longbridge.com/en/news/302964592.md)
- [If I could only invest $500 in AI this month, I'd buy this 1 stock](https://longbridge.com/en/news/302565884.md)
- [I'd Buy Half a Position in Amazon Stock Before Its Oct. 29 Report -- and Half After](https://longbridge.com/en/news/303054275.md)
- [AppLovin Corporation $APP Stock Purchased by Hedeker Wealth LLC](https://longbridge.com/en/news/303049441.md)
- [EULAV Asset Management Acquires 9,727 Shares of Moderna, Inc. $MRNA](https://longbridge.com/en/news/303047245.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**